UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 148

Sortiert nach

Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis

Cancer research (Chicago, Ill.), 2005-11, Vol.65 (22), p.10174-10178

2005

Volltextzugriff (PDF)

Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers

Cancer research (Chicago, Ill.), 2017-09, Vol.77 (18), p.5194-5206

2017

Volltextzugriff (PDF)

MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions

Cancer research (Chicago, Ill.), 2008-10, Vol.68 (20), p.8195-8200

2008

Volltextzugriff (PDF)

Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis

Cancer research (Chicago, Ill.), 1998-02, Vol.58 (3), p.409-412

1998

Volltextzugriff (PDF)

Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis

Cancer research (Chicago, Ill.), 2000-01, Vol.60 (2), p.293-297

2000

Volltextzugriff (PDF)

Abstract 4501: RNA seq analysis reveals altered immune specific gene signature in African American bladder cancer

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4501-4501

2020

Volltextzugriff (PDF)

MicroRNA-661, a c/EBPα. Target, Inhibits Metastatic Tumor Antigen 1 and Regulates Its Functions

Cancer research (Chicago, Ill.), 2009-07, Vol.69 (14), p.5639-5642

2009

Volltextzugriff (PDF)

MTA1 Promotes STAT3 Transcription and Pulmonary Metastasis in Breast Cancer

Cancer research (Chicago, Ill.), 2013-06, Vol.73 (12), p.3761-3770

2013

Volltextzugriff (PDF)

Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis

Cancer research (Chicago, Ill.), 1996-10, Vol.56 (20), p.4566-4569

1996

Volltextzugriff (PDF)

Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells

Cancer research (Chicago, Ill.), 2003-03, Vol.63 (5), p.972-979

2003

Volltextzugriff (PDF)

Abstract 2224: Validated differential expression of immunoregulatory molecules that coincide with targetable mutations may provide novel insights into strategic trial design for therapeutics

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.2224-2224

2020

Volltextzugriff (PDF)

Abstract 6712: Analysis of VEGF as a potential complimentary target with immunotherapy

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.6712-6712

2020

Volltextzugriff (PDF)

EN1 Is a Transcriptional Dependency in Triple-Negative Breast Cancer Associated with Brain Metastasis

Cancer research (Chicago, Ill.), 2019-08, Vol.79 (16), p.4173-4183

2019

Volltextzugriff (PDF)

EphB4 expression and biological significance in prostate cancer

Cancer research (Chicago, Ill.), 2005-06, Vol.65 (11), p.4623-4632

2005

Volltextzugriff (PDF)

Abstract 4429: Delivery of miR-143 and miR-506 with novel nano carrier to arrest cell cycle in lung cancer

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4429-4429

2019

Volltextzugriff (PDF)

Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: Identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators

Cancer research (Chicago, Ill.), 2004-02, Vol.64 (3), p.1050-1057

2004

Volltextzugriff (PDF)

Abstract 5783: Strong antitumor activity of ASN007, an oral ERK1/2 inhibitor, in PDX tumor models with MAP kinase pathway alterations including KRAS mutations

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5783-5783

2018

Volltextzugriff (PDF)

Abstract 694: Structure-function analysis of RPL18A, a putative binding target of rigosertib

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.694-694

2015

Volltextzugriff (PDF)

Abstract 3029: Dual targeting of ARK5 and CDK4 pathways with ON 123300 as a therapeutic strategy for colorectal carcinoma

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3029-3029

2016

Volltextzugriff (PDF)

Abstract 187: ASN0007, a potent ERK1/2 inhibitor with strong antitumor activity in multiple RAS mutant models

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.187-187

2016

Volltextzugriff (PDF)

Abstract 187: ASN0007, a potent ERK12 inhibitor with strong antitumor activity in multiple RAS mutant models

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.187-187

2016

Volltextzugriff (PDF)

Deregulation of Caspase 8 and 10 expression in pediatric tumors and cell lines

Cancer research (Chicago, Ill.), 2002-10, Vol.62 (20), p.5897-5901

2002

Volltextzugriff (PDF)

Abstract GS2-10: Nimbus: A phase 2 trial of nivolumab plus ipilimumab for patients with hypermutated her2-negative metastatic breast cancer (MBC)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.GS2-10-GS2-10

2022

Volltextzugriff (PDF)

Abstract 2666: HMGA1: An epigenetic switch required for MPN progression by inducing GATA-2 and cell cycle progression through enhancer rewiring

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2666-2666

2021

Volltextzugriff (PDF)

Abstract 4204: ASN002: A novel dual SYK/JAK inhibitor with strong antitumor activity in both hematological and solid tumor xenograft models

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4204-4204

2017

Volltextzugriff (PDF)

1 – 25 von 148

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(148)

Publikationsform

Artikel
(148)

Sprache

Englisch
(148)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Animals
(54)
Life Sciences & Biomedicine
(50)
Oncology
(50)
Science & Technology
(50)
Biological And Medical Sciences
(44)
Medical Sciences
(41)
Rats
(38)
Male
(35)
Tumors
(33)
Rats, Inbred F344
(26)
Carcinogenesis, Carcinogens And Anticarcinogens
(19)
Humans
(19)
Mice
(19)
Female
(18)
Chemical Agents
(15)
Microbodies - Drug Effects
(13)
Pharmacology. Drug Treatments
(11)
Colonic Neoplasms - Prevention & Control
(10)
Antineoplastic Agents
(9)
Colonic Neoplasms - Chemically Induced
(9)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Menü

Weitere Dienste

Einstellungen

Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis

Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers

MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions

Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis

Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis

Abstract 4501: RNA seq analysis reveals altered immune specific gene signature in African American bladder cancer

MicroRNA-661, a c/EBPα. Target, Inhibits Metastatic Tumor Antigen 1 and Regulates Its Functions

MTA1 Promotes STAT3 Transcription and Pulmonary Metastasis in Breast Cancer

Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis

Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells

Abstract 2224: Validated differential expression of immunoregulatory molecules that coincide with targetable mutations may provide novel insights into strategic trial design for therapeutics

Abstract 6712: Analysis of VEGF as a potential complimentary target with immunotherapy

EN1 Is a Transcriptional Dependency in Triple-Negative Breast Cancer Associated with Brain Metastasis

EphB4 expression and biological significance in prostate cancer

Abstract 4429: Delivery of miR-143 and miR-506 with novel nano carrier to arrest cell cycle in lung cancer

Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: Identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators

Abstract 5783: Strong antitumor activity of ASN007, an oral ERK1/2 inhibitor, in PDX tumor models with MAP kinase pathway alterations including KRAS mutations

Abstract 694: Structure-function analysis of RPL18A, a putative binding target of rigosertib

Abstract 3029: Dual targeting of ARK5 and CDK4 pathways with ON 123300 as a therapeutic strategy for colorectal carcinoma

Abstract 187: ASN0007, a potent ERK1/2 inhibitor with strong antitumor activity in multiple RAS mutant models

Abstract 187: ASN0007, a potent ERK12 inhibitor with strong antitumor activity in multiple RAS mutant models

Deregulation of Caspase 8 and 10 expression in pediatric tumors and cell lines

Abstract GS2-10: Nimbus: A phase 2 trial of nivolumab plus ipilimumab for patients with hypermutated her2-negative metastatic breast cancer (MBC)

Abstract 2666: HMGA1: An epigenetic switch required for MPN progression by inducing GATA-2 and cell cycle progression through enhancer rewiring

Abstract 4204: ASN002: A novel dual SYK/JAK inhibitor with strong antitumor activity in both hematological and solid tumor xenograft models

Aktive Filter

Suchergebnisse filtern